丽珠医药8月1日斥资7.14万元回购1700股A股

Group 1 - The company, Lijun Pharmaceutical (01513), announced a share buyback plan [1] - The buyback will occur on August 1, 2025, with an investment of RMB 71,400 [1] - The company plans to repurchase 1,700 A-shares at a price of RMB 41.99 per share [1]